oxis turbuhaler innöndunarduft 4,5 míkrog/skammt
astrazeneca a/s - formoterolum fúmarat - innöndunarduft - 4,5 míkrog/skammt
oxis turbuhaler innöndunarduft 9 míkróg/skammt
astrazeneca a/s - formoterolum fúmarat - innöndunarduft - 9 míkróg/skammt
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - lungnasjúkdómur, langvarandi hindrandi - lyf til veikindi öndunarvegi sjúkdómum, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - lungnasjúkdómur, langvarandi hindrandi - lyf til veikindi öndunarvegi sjúkdómum, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
symbicort turbuhaler (lyfjaver) noregur innöndunarduft 160/4,5 míkróg/skammt
lyfjaver ehf. - budesonidum inn; formoterolum inn fúmarat - innöndunarduft - 160/4,5 míkróg/skammt